premenstrual%20dysphoric%20disorder
PREMENSTRUAL DYSPHORIC DISORDER
Premenstrual dysphoric disorder is a cyclical disorder presenting with distressing mood and behavioral symptoms that occur during the late luteal phase of the ovulatory cycle; it is a severe form of premenstrual syndrome.
It results in considerable impairment of the patient's personal functioning that occurs in approximately 5% of women of reproductive age.

Premenstrual%20dysphoric%20disorder Patient Education

Patient Education

  • Emphasize the need to seek help due to the following reasons:
    • PMDD tends to recur each cycle and may become severe over time
    • This dysfunction can be readily diagnosed and effectively treated
  • Advise regarding the benefits and risks of each therapeutic agent and how to safely stop drug intake 
  • Inform the patient regarding the mixed results of studies on complementary medicines 
  • Educate both the patient and the family/spouse as this disorder impacts on the entire family context

Lifestyle Modification

Diet Modification

  • Dietary changes can have a noticeable impact on PMS severity
    • Reduction of caffeine intake may diminish anxiety and irritability
    • Decreasing Na intake can lessen bloating and edema
    • Patients should also be encouraged to reduce intake of refined sugar and eat small balanced meals rich in complex carbohydrates

Increase in Physical Exercise

  • Has been shown to significantly improve mood and decrease lethargy
  • Evidence of effect is largely anecdotal but can be advised as part of healthy lifestyle
  • Aerobic exercise for 20-30 min, 3-4x/week has been recommended
  • Reduction of body weight to within 20% of ideal is an appropriate goal
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
While early-phase clinical trials may demonstrate substantial levels of overall response rates in patients with relapsed/refractory multiple myeloma (RRMM), high heterogeneity of evidence prevents the accurate assessment of clinical benefit before patient participation, reports a recent meta-analysis.
Elvira Manzano, 28 Mar 2021
The COVID-19 vaccine AZD1222 by AstraZeneca and the University of Oxford was 79 percent effective overall in preventing symptomatic infections – higher than observed in previous clinical trials of the vaccine – at the interim analysis of a US phase III trial.
2 days ago
The chances of a live birth following either fresh or frozen-thawed embryo transfer cycles cannot be predicted by endometrial thickness alone, according to a study.
01 Apr 2021
Migraine and headache are common ailments of people living in the modern era. Dr Jon Marshall of The Singapore Headache and Migraine Clinic shares his insights with Pearl Toh on how to manage migraine and headache using non-pharmaceutical strategies, with a focus on the manual medicine approach.